跳至主要内容
临床试验/NCT04598971
NCT04598971Unknown不适用

Consequences of UTI on Urine pH

Centre Hospitalier Universitaire Vaudois1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2020年8月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
50
试验地点
1
主要终点
Urine pH

研究概览

简要总结

Urinary tract infections (UTI) affect the urine pH and may lead to salt precipitation such as struvite. Bacteria with urease activity are known to alkalinise urine, but not much is known on how pH is changing over time during UTI.

This study aims at following urine pH progression at the time of diagnosis of UTI and during the treatment phase.

Description of the change in urine pH over time will help understanding the risk of struvite formation and potential timing of intervention.

详细描述

Adults presenting with UTI symptoms will be screened for infection and instructed to monitor urine pH during the course of treatment and 1 week after. Urine pH will be measured by the patients using calibrated pH-stix. Type of bacteria, antibiotics, and the type of diet will be monitored during the study.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Symptoms of dysuria, pollakiuria, no fever AND
  • urine-stix positive for leucocytes OR positive culture (>10E5 cfu/ml)
  • Pyelonephritis
  • Inclusion Criteria:
  • Unilateral flank pain, pollakiuria, dysuria, fever (>38.5°C) AND
  • urine-stix positive for leucocytes OR positive culture (>10E5 cfu/ml)
  • Exclusion Criteria (both groups):
  • known urinary tract anatomic abnormalities
  • Presence of a urine catheter
  • Sepsis - septic shock
  • Patient taking drug interfering with urine pH (diuretics, citrate, acetazolamide, topiramate,...)
  • Patients with UTI diagnosed in the preceding month
  • Patients having received antibiotics during the preceding month
  • Male patient with a diagnosis of prostatitis
  • Presence of infected kidney cyst
  • Patient with diabetes
  • Pregnant female
  • Patient with obstructive pyelonephritis

排除标准

  • 未提供

结局指标

主要结局

Urine pH

时间窗: 21 days

Urine pH is monitored by the patient every morning during the treatment phase and 7 days after the end of treatment

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Olivier Bonny

Associate professor

Centre Hospitalier Universitaire Vaudois

研究点 (1)

Loading locations...

相似试验